Truist Securities Maintains Buy on American Healthcares, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on American Healthcares (NYSE:AHR) and increased the price target from $17 to $22, indicating confidence in the company's future performance.

September 03, 2024 | 11:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reaffirmed its Buy rating on American Healthcares and increased the price target from $17 to $22, suggesting a positive outlook for the company's stock.
The increase in price target from $17 to $22 by Truist Securities indicates a strong positive outlook for American Healthcares. The maintained Buy rating suggests continued confidence in the company's performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100